Last €21.80 EUR
Change Today -0.146 / -0.67%
Volume 404.0
GM0N On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 12:33 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

globus medical inc - a (GM0N) Snapshot

Open
€22.31
Previous Close
€21.95
Day High
€22.31
Day Low
€21.80
52 Week High
02/27/15 - €22.31
52 Week Low
08/19/14 - €13.58
Market Cap
2.1B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
70.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GLOBUS MEDICAL INC - A (GM0N)

globus medical inc - a (GM0N) Related Businessweek News

No Related Businessweek News Found

globus medical inc - a (GM0N) Details

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. It offers approximately 120 products that address an array of spinal pathologies, anatomies, and surgical approaches. The company’s fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Its disruptive technology products provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies; and interventional pain management solutions, including treatments for vertebral compression fractures. The company has received pre-market approval for SECURE-C Cervical Artificial Disc; and conducting other clinical trials for ACADIA Facet Replacement System, a motion preserving anatomic reconstruction of the facet joint intended for the treatment of spinal stenosis, as well as TRIUMPH Lumbar Disc, a motion preserving disc replacement inserted obliquely into the disc space from a posterolateral approach to address posterior spinal pathology and maintain important anterior anatomical structures. Globus Medical, Inc. sells its implants and related disposables primarily to hospitals. The company markets and sells its products through sales representatives and independent distributors in the United States and internationally. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.

Founded in 2003

globus medical inc - a (GM0N) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $389.7K
President, Interim Chief Financial Officer, C...
Total Annual Compensation: $324.8K
Co-Founder, Senior Vice President of Operatio...
Total Annual Compensation: $227.3K
Executive Vice President of US Sales
Total Annual Compensation: $297.4K
Compensation as of Fiscal Year 2013.

globus medical inc - a (GM0N) Key Developments

Globus Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Globus Medical, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported sales of $128,801,000 compared to $115,245,000 a year ago. Operating income was $39,644,000 compared to $31,747,000 a year ago. Income before income taxes was $39,478,000 compared to $31,820,000 a year ago. Net income was $27,638,000 or $0.29 per basic and diluted share compared to $20,985,000 or $0.22 per basic and diluted share a year ago. Adjusted EBITDA was $47,262,000 compared to $42,934,000 a year ago. Non-GAAP net income was $28,776,000 or $0.30 per diluted share compared to $24,022,000 or $0.25 per diluted share a year ago. Net cash provided by operating activities was $1,945,000 compared to $32,658,000 a year ago. Purchases of property and equipment were $9,095,000 compared to $5,205,000 a year ago. Adjusted EBITDA was $47,262,000 compared to $42,934,000 a year ago. Non-GAAP free cash flow was $16,220,000 compared to $27,453,000 a year ago. For the year, the company reported sales of $474,371,000 compared to $434,459,000 a year ago. Operating income was $138,362,000 compared to $101,673,000 a year ago. Income before income taxes was $138,642,000 compared to $102,001,000 a year ago. Net income was $92,485,000 or $0.97 per diluted share compared to $68,612,000 or $0.73 per diluted share a year ago. Net cash provided by operating activities was $79,172,000 compared to $93,471,000 a year ago. Purchases of property and equipment were $24,754,000 compared to $23,680,000 a year ago. Adjusted EBITDA was $171,432,000 compared to $150,543,000 a year ago. Non-GAAP net income was $96,150,000 or $1.01 per diluted share compared to $84,362,000 or $0.90 per diluted share a year ago. Non-GAAP free cash flow was $77,788,000 compared to $69,791,000 a year ago.

Globus Medical, Inc. to Report Q4, 2014 Results on Feb 25, 2015

Globus Medical, Inc. announced that they will report Q4, 2014 results at 5:30 PM, US Eastern Standard Time on Feb 25, 2015

Globus Medical, Inc., Q4 2014 Earnings Call, Feb 25, 2015

Globus Medical, Inc., Q4 2014 Earnings Call, Feb 25, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GM0N:GR €21.80 EUR -0.146

GM0N Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Integra LifeSciences Holdings Corp $60.01 USD +1.78
K2M Group Holdings Inc $20.49 USD -0.50
NuVasive Inc $45.75 USD +0.76
Orthofix International NV $32.43 USD +0.23
RTI Surgical Inc $5.32 USD +0.12
View Industry Companies
 

Industry Analysis

GM0N

Industry Average

Valuation GM0N Industry Range
Price/Earnings 27.7x
Price/Sales 5.1x
Price/Book 4.3x
Price/Cash Flow 27.5x
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLOBUS MEDICAL INC - A, please visit www.globusmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.